{"id":32196,"date":"2026-07-08T00:00:00","date_gmt":"2026-07-07T22:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=48e16e225098c0ea42fc2714a48e4208"},"modified":"2026-07-08T00:00:00","modified_gmt":"2026-07-07T22:00:00","slug":"longeviti-launches-clearfit-ai-a-brain-ultrasound-interface-bui-to-advance-platform-solutions-for-neurological-disorders","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=32196","title":{"rendered":"Longeviti Launches ClearFit AI\u2122, a Brain Ultrasound Interface (BUI) to Advance Platform Solutions for Neurological Disorders"},"content":{"rendered":"<p>\nThe ClearFit AI integrated platform combines sonolucent implant technology, bedside ultrasound imaging, and artificial intelligence to support the future of postoperative brain visualization.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260625051733\/en\/2839913\/5\/Picture1.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260625051733\/en\/2839913\/22\/Picture1.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260625051733\/en\/2839913\/5\/Picture1.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260625051733\/en\/2839913\/21\/Picture1.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260625051733\/en\/2839912\/5\/bold_logo_gradient.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260625051733\/en\/2839912\/22\/bold_logo_gradient.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260625051733\/en\/2839912\/5\/bold_logo_gradient.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260625051733\/en\/2839912\/21\/bold_logo_gradient.jpg\" \/><\/a><p>BALTIMORE, Md.--(BUSINESS WIRE)--<a href=\"https:\/\/twitter.com\/hashtag\/AI?src=hash\" >#AI<\/a>--Longeviti Neuro Solutions, a neurotechnology company focused on advancing innovative solutions that unlock post-operative ultrasound access to the brain, today announced the launch of two strategic initiatives, <b>ClearFit AI\u2122, a Brain Ultrasound Interface (BUI). <\/b>Together, these technologies create a persistent acoustic interface to the brain, enabling real-time bedside imaging and supporting future advances in AI-assisted neurosurgical care.<\/p><p>\nThe ClearFit AI\u2122 platform combines:<\/p><ul class=\"bwlistdisc\">\n<li>\nClearFit<sup>\u00ae<\/sup> sonolucent cranial implants<\/li>\n<li>\nUltrasound compatibility<\/li>\n<li>\nClinical workflow and training support<\/li>\n<li>\nAI-enhanced imaging<\/li>\n<\/ul><p>\nThis platform enables the Brain Ultrasound Interface (BUI) \u2014 a new category of post-operative neuro access that may reduce reliance on CT and MRI transport, integrate into existing neuro workflows, and position the implant site as a potential foundation for future applications currently under investigation.<\/p><p>\n<b>Operational and Economic Potential<\/b><\/p><p>\nAs healthcare systems continue to evaluate scalable and cost-conscious technologies, ultrasound-enabled imaging approaches may offer operational advantages in select care environments.<\/p><p>\nAdjunct imaging technologies may contribute to:<\/p><ul class=\"bwlistdisc\">\n<li>\nExpanded bedside visualization capabilities<\/li>\n<li>\nReduce operational transport burdens<\/li>\n<li>\nIncreased accessibility to imaging technologies<\/li>\n<li>\nImaging workflow efficiency and process optimization<\/li>\n<\/ul><p>\nAny future clinical, operational, or economic benefits will depend on regulatory review, validation activities, adoption patterns, and real-world implementation.<\/p><p>\n<b>Beyond the Implant<\/b><\/p><p>\nFor clinicians, BUI means the ability to assess the brain at the bedside \u2014 possibly reducing operational burdens such as scheduling imaging, transporting a post-operative patient, or waiting for results. ClearFit AI\u2122 makes that possible by turning the implant site into a persistent sonolucent interface, with AI-assisted imaging optimization only available on Clarius Ultrasound units.<\/p><p>\nFor patients, that access may mean fewer trips to the scanner, less radiation exposure, and bedside visualization that may extend from the ICU into outpatient and recovery settings.<\/p><p>\n\u201cThe mission was always in the name,\u201d said Jesse Christopher, CEO. \u201cLongeviti exists to pursue scalable platform technologies that help create new possibilities for clinicians, researchers, and patients while supporting the broader goal of protecting cognitive function and improving quality of life.\u201d<\/p><p>\n<b>About Longeviti Neuro Solutions<\/b><\/p><p>\nLongeviti Neuro Solutions is a US-based neurotechnology company pioneering the future of neurosurgical platform solutions. Our ClearFit AI, a Brain Ultrasound Interface (BUI) \u2014 an innovative solution that unlocks post-operative ultrasound access to the brain, giving clinicians unprecedented visibility into recovery. Longeviti Neuro Solutions designs and manufactures ultrasound-penetrable FDA-cleared implants that power the ClearFit AI\u2122 platform \u2014 allowing bedside, AI-assisted ultrasound imaging, and visualization, and post-operative neurosurgical care.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\n<b>Media Contact<\/b><br\/>Gabby Waldron\n<br\/>Manager of Marketing &amp; Training\n<br\/>Longeviti Neuro Solutions\n<br\/><a  href=\"mailto:gwaldron@longeviti.com\" rel=\"nofollow\" shape=\"rect\">gwaldron@longeviti.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The ClearFit AI integrated platform combines sonolucent implant technology, bedside ultrasound imaging, and artificial intelligence to support the future of postoperative brain visualization.BALTIMORE, Md.&#8211;(BUSINESS WIRE)&#8211;#AI&#8211;Longeviti Neuro Soluti&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-32196","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/32196","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=32196"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/32196\/revisions"}],"predecessor-version":[{"id":32197,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/32196\/revisions\/32197"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=32196"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=32196"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=32196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}